REGIONAL BODY FAT AND METABOLIC COMPLICATIONS IN CHILDREN WITH FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN VARIETY (FPLD2)

被引：0
|
作者：
Patni, Nivedita [1 ]
Adams-Huet, Beverley [1 ]
Garg, Abhimanyu [1 ]
机构：
[1] UT Southwestern Med Ctr, Dallas, TX USA
来源：
HORMONE RESEARCH IN PAEDIATRICS | 2017年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1-1122
引用
收藏
页码：164 / 165
页数：2
相关论文
共 50 条
  • [41] A New Method for Body Fat Evaluation, Body Adiposity Index, Is Useful in Women With Familial Partial Lipodystrophy
    Godoy-Matos, Amelio F.
    Moreira, Rodrigo O.
    Valerio, Cynthia M.
    Mory, Patricia B.
    Moises, Regina S.
    OBESITY, 2012, 20 (02) : 440 - 443
  • [42] Clinical presentations, metabolic abnormalities and end-organ complications in patients with familial partial lipodystrophy
    Akinci, Baris
    Onay, Huseyin
    Demir, Tevfik
    Savas-Erdeve, Senay
    Gen, Ramazan
    Simsir, Ilgin Yildirim
    Keskin, Fatma Ela
    Erturk, Mehmet Sercan
    Uzum, Ayse Kubat
    Yaylali, Guzin Fidan
    Ozdemir, Nilufer Kutbay
    Atik, Tahir
    Ozen, Samim
    Yurekli, Banu Sarer
    Apaydin, Tugce
    Altay, Canan
    Akinci, Gulcin
    Demir, Leyla
    Comlekci, Abdurrahman
    Secil, Mustafa
    Oral, Elif Arioglu
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2017, 72 : 109 - 119
  • [43] Metabolic profile in women with Dunnigan-type partial familial lipodystrophy caused by R482W mutation in the LMNA gene
    Foss-Freitas, M. C.
    Monteiro, L. Z.
    Coeli, F. B.
    Pereira, F. A.
    Montenegro Junior, R. M.
    Foss, M. C.
    DIABETOLOGIA, 2011, 54 : S512 - S512
  • [44] Generation of an isogenic gene-corrected iPSC line (PUMCHi001-A-1) from a familial partial lipodystrophy type 2 (FPLD2) patient with a heterozygous R349W mutation in the LMNA gene
    Xiao, Cheng
    Yu, Miao
    Liu, Jieying
    Wu, Han
    Deng, Mingqun
    Zhang, Qian
    Xiao, Xinhua
    STEM CELL RESEARCH, 2020, 44
  • [45] Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C
    Speckman, RA
    Garg, A
    Du, FH
    Bennett, L
    Veile, R
    Arioglu, E
    Taylor, SI
    Lovett, M
    Bowcock, AM
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 66 (04) : 1192 - 1198
  • [46] Assessment of efficacy and safety of volanesorsen for treatment of metabolic complications in patients with familial partial lipodystrophy: Results of the BROADEN study
    Oral, Elif A.
    Garg, Abhimanyu
    Tami, Joseph
    Huang, Eric A.
    O'Dea, Louis St. L.
    Schmidt, Hartmut
    Tiulpakov, Anatoly
    Mertens, Ann
    Alexander, Veronica J.
    Watts, Lynnetta
    Hurh, Eunju
    Witztum, Joseph L.
    Geary, Richard S.
    Tsimikas, Sotirios
    JOURNAL OF CLINICAL LIPIDOLOGY, 2022, 16 (06) : 833 - 849
  • [47] INSULIN-RESISTANCE AND BODY-FAT DISTRIBUTION IN A MALE-PATIENT WITH FAMILIAL PARTIAL LIPODYSTROPHY (FPL)
    GARG, A
    FLECKENSTEIN, JL
    ABATE, N
    CLINICAL RESEARCH, 1994, 42 (02): : A199 - A199
  • [48] Analysis of Fat Shadows, Bone Mineral Density (BMD) and body composition in patients with Partial Familial Lipodystrophy (PFL)
    Moreira, Mariana
    Silva, Maisa
    de Araujo, Iana
    de Paula, Francisco
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 185 - 185
  • [49] Dipeptidyl peptidase-4 levels are increased and partially related to body fat distribution in patients with familial partial lipodystrophy type 2
    Cynthia Melissa Valerio
    Juliana Severo de Almeida
    Rodrigo Oliveira Moreira
    Luiza Barreto. S. Aguiar
    Priscila O. Siciliano
    Denise P. Carvalho
    Amelio F. Godoy-Matos
    Diabetology & Metabolic Syndrome, 9
  • [50] Dipeptidyl peptidase-4 levels are increased and partially related to body fat distribution in patients with familial partial lipodystrophy type 2
    Valerio, Cynthia Melissa
    de Almeida, Juliana Severo
    Moreira, Rodrigo Oliveira
    Aguiar, Luiza Barreto. S.
    Siciliano, Priscila O.
    Carvalho, Denise P.
    Godoy-Matos, Amelio F.
    DIABETOLOGY & METABOLIC SYNDROME, 2017, 9
12345